These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29376542)

  • 1. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
    Hu Y; Mignani S; Majoral JP; Shen M; Shi X
    Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fe
    Li Y; Zhang H
    Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
    Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
    Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T
    Shen Z; Chen T; Ma X; Ren W; Zhou Z; Zhu G; Zhang A; Liu Y; Song J; Li Z; Ruan H; Fan W; Lin L; Munasinghe J; Chen X; Wu A
    ACS Nano; 2017 Nov; 11(11):10992-11004. PubMed ID: 29039917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous-phase synthesis of iron oxide nanoparticles and composites for cancer diagnosis and therapy.
    Li J; Wang S; Shi X; Shen M
    Adv Colloid Interface Sci; 2017 Nov; 249():374-385. PubMed ID: 28335985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications.
    Abedin MR; Umapathi S; Mahendrakar H; Laemthong T; Coleman H; Muchangi D; Santra S; Nath M; Barua S
    J Nanobiotechnology; 2018 Oct; 16(1):80. PubMed ID: 30316298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2D Superparamagnetic Tantalum Carbide Composite MXenes for Efficient Breast-Cancer Theranostics.
    Liu Z; Lin H; Zhao M; Dai C; Zhang S; Peng W; Chen Y
    Theranostics; 2018; 8(6):1648-1664. PubMed ID: 29556347
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
    Du Y; Liu X; Liang Q; Liang XJ; Tian J
    Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices.
    Hajba L; Guttman A
    Biotechnol Adv; 2016; 34(4):354-361. PubMed ID: 26853617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells.
    Soleymani M; Khalighfard S; Khodayari S; Khodayari H; Kalhori MR; Hadjighassem MR; Shaterabadi Z; Alizadeh AM
    Sci Rep; 2020 Feb; 10(1):1695. PubMed ID: 32015364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia.
    Wang C; Hsu CH; Li Z; Hwang LP; Lin YC; Chou PT; Lin YY
    Int J Nanomedicine; 2017; 12():6273-6287. PubMed ID: 28894366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
    Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
    Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer.
    Thomas R; Park IK; Jeong YY
    Int J Mol Sci; 2013 Jul; 14(8):15910-30. PubMed ID: 23912234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics.
    Luo Y; Tang Y; Liu T; Chen Q; Zhou X; Wang N; Ma M; Cheng Y; Chen H
    Chem Commun (Camb); 2019 Feb; 55(13):1963-1966. PubMed ID: 30681672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.